Univariate regression analysis | Multivariate regression analysis | ||||
Standardised coefficient | p Value | r2 | Standardised coefficient | p Value | |
Age (years) | 0.44 | <0.001 | 0.20 | 0.32 | <0.001 |
Female gender | −0.06 | 0.019 | <0.01 | −0.12 | <0.001 |
Smoking/quit smoking <1 year | 0.12 | <0.001 | <0.01 | 0.18 | <0.001 |
BMI (kg/m2) | 0.26 | <0.001 | 0.07 | 0.16 | <0.001 |
Systolic BP (mm Hg) | 0.24 | <0.001 | 0.06 | ||
Diastolic BP (mm Hg) | 0.16 | <0.001 | 0.03 | ||
Heart rate (bpm) | 0.05 | <0.001 | <0.01 | 0.03 | 0.014 |
Myocardial infarction | 0.50 | <0.001 | 0.01 | ||
Cerebrovascular accident | 0.52 | 0.008 | <0.01 | ||
Hypertension | 0.53 | <0.001 | 0.06 | ||
Hypercholesterolaemia | 0.38 | <0.001 | 0.03 | ||
Diabetes mellitus | 0.76 | <0.001 | 0.02 | 0.23 | 0.016 |
Glucose (mmol/l) | 0.19 | <0.001 | 0.03 | ||
Total cholesterol (mmol/l) | 0.17 | <0.001 | 0.03 | ||
HDL cholesterol (mmol/l) | −0.10 | <0.001 | 0.01 | ||
Triglycerides (mmol/l) | 0.15 | <0.001 | 0.02 | ||
C reactive protein (mg/l) | 0.19 | <0.001 | 0.04 | ||
NT-proBNP (ng/l) | 0.22 | <0.001 | 0.05 | 0.12 | <0.001 |
UAE (mg/24 h) | 0.15 | <0.001 | 0.02 | ||
Cystatin-C (mg/l) | 0.27 | <0.001 | 0.09 | 0.15 | <0.001 |
eGFR (ml/min/1.73 m2) | −0.31 | <0.001 | 0.10 |
Dependent factor: mid-regional portion of pro-adrenomedullin (MR-proADM).
BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL cholesterol, high-density lipoprotein cholesterol; NT-proBNP, N-terminal pro-brain-type natriuretic peptide; UAE, urinary albumin excretion.